€262.50
0.83% today
Xetra, Feb 05, 01:15 pm CET
ISIN
DE0007165631
Symbol
SRT3
Index
Sector

Sartorius Vz Stock price

€264.70
+41.40 18.54% 1M
+22.00 9.06% 6M
+49.50 23.00% YTD
-68.90 20.65% 1Y
-198.80 42.89% 3Y
+44.30 20.10% 5Y
+237.44 870.93% 10Y
Xetra, Closing price Tue, Feb 04 2025
-7.40 2.72%
ISIN
DE0007165631
Symbol
SRT3
Index
Sector

Key metrics

Market capitalization €18.27b
Enterprise Value €23.33b
P/E (TTM) P/E ratio 70.80
EV/FCF (TTM) EV/FCF 83.14
EV/Sales (TTM) EV/Sales 7.02
P/S ratio (TTM) P/S ratio 5.50
P/B ratio (TTM) P/B ratio 6.85
Dividend yield 0.28%
Last dividend (FY23) €0.74
Revenue growth (TTM) Revenue growth -7.87%
Revenue (TTM) Revenue €3.32b
EBIT (operating result TTM) EBIT €486.30m
Free Cash Flow (TTM) Free Cash Flow €280.60m
Cash position €579.20m
EPS (TTM) EPS €1.21
P/E forward 131.35
P/S forward 5.14
EV/Sales forward 6.65
Show more

Create a Free Account to create an Sartorius Vz alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Sartorius Vz Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Sartorius Vz forecast:

10x Buy
48%
8x Hold
38%
3x Sell
14%

Analyst Opinions

21 Analysts have issued a Sartorius Vz forecast:

Buy
48%
Hold
38%
Sell
14%

Financial data from Sartorius Vz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3,324 3,324
8% 8%
100%
- Direct Costs 1,863 1,863
3% 3%
56%
1,461 1,461
19% 19%
44%
- Selling and Administrative Expenses 403 403
14% 14%
12%
- Research and Development Expense 185 185
4% 4%
6%
872 872
32% 32%
26%
- Depreciation and Amortization 386 386
13% 13%
12%
EBIT (Operating Income) EBIT 486 486
48% 48%
15%
Net Profit 83 83
76% 76%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Sartorius Vz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sartorius Vz Stock News

EQS
8 days ago
Göttingen, 28. Januar 2025 Sartorius schließt Geschäftsjahr 2024 mit sehr gutem 4. Quartal und positivem Trend ab; Gesamtjahresprognose erreicht   Vorläufige Geschäftsergebnisse für 2024: Umsatz bei 3.381 Millionen Euro (+0,1 Prozent wechselkursbereinigt), operative Ertragsmarge erreicht 28,...
AD HOC NEWS
9 days ago
(Neufassung des letzten Satzes.)GÖTTINGEN - Nach einem weiteren schwierigen Jahr soll es beim Labor- und Pharmazulieferer Sartorius DE0007165631 endlich wieder aufwärtsgehen.
More Sartorius Vz News

Company Profile

Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Head office Germany
CEO Joachim Kreuzburg
Employees 13,528
Founded 1870
Website www.sartorius.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today